Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ZYNE

Zynerba

$19.43

0.49 (2.59%)

, GWPH

GW Pharmaceuticals

$106.15

-0.52 (-0.49%)

14:29
07/17/17
07/17
14:29
07/17/17
14:29
Hot Stocks
Before the Move: Watch Zynerba ahead of trial data »

With Zynerba…

ZYNE

Zynerba

$19.43

0.49 (2.59%)

GWPH

GW Pharmaceuticals

$106.15

-0.52 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.94

0.24 (0.64%)

, LB

Labarge

$54.26

-0.15 (-0.28%)

07:30
06/29/17
06/29
07:30
06/29/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

T

AT&T

$37.94

0.24 (0.64%)

LB

Labarge

$54.26

-0.15 (-0.28%)

HST

Host Hotels

$18.60

-0.01 (-0.05%)

CPN

Calpine

$13.74

-0.02 (-0.15%)

CHRW

C.H. Robinson

ZYNE

Zynerba

$18.52

-0.41 (-2.17%)

H

Hyatt

$57.38

0.29 (0.51%)

MTGE

MTGE Investment Corp.

$18.80

-0.3 (-1.57%)

MFA

MFA Financial

$8.43

0.08 (0.96%)

MITT

AG Mortgage

$18.48

-0.22 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

  • 27

    Jul

ZYNE

Zynerba

$18.93

-0.19 (-0.99%)

10:40
06/28/17
06/28
10:40
06/28/17
10:40
Options
Put buyer opens a notable new position in Zynerba Pharmaceuticals »

Put buyer opens a notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$18.77

0.74 (4.10%)

07:31
06/26/17
06/26
07:31
06/26/17
07:31
Hot Stocks
Zynerba initiates Phase 1 ZYN001 clinical program »

Zynerba Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$18.77

0.74 (4.10%)

07:15
06/26/17
06/26
07:15
06/26/17
07:15
Recommendations
Zynerba analyst commentary at Oppenheimer »

Zynerba risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

, GWPH

GW Pharmaceuticals

$94.99

0.85 (0.90%)

07:58
06/12/17
06/12
07:58
06/12/17
07:58
Recommendations
Zynerba, GW Pharmaceuticals analyst commentary at Maxim »

Zynerba an…

ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

GWPH

GW Pharmaceuticals

$94.99

0.85 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

16:38
06/09/17
06/09
16:38
06/09/17
16:38
Syndicate
Breaking Syndicate news story on Zynerba »

Zynerba files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$18.77

0.24 (1.30%)

07:52
06/08/17
06/08
07:52
06/08/17
07:52
Hot Stocks
Zynerba achieves target enrollment in trial evaluating ZYN002 »

Zynerba Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

ZYNE

Zynerba

$19.75

0.51 (2.65%)

07:59
05/09/17
05/09
07:59
05/09/17
07:59
Hot Stocks
Zynerba reports cash and equivalents $77.5M as of March 31 »

As of March 31 cash and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ZYNE

Zynerba

$19.75

0.51 (2.65%)

07:58
05/09/17
05/09
07:58
05/09/17
07:58
Earnings
Zynerba reports Q1 EPS (60c), consensus (55c) »

Reports Q1 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.